132 related articles for article (PubMed ID: 36930846)
1. Correlation of N-terminal-pro-brain natriuretic peptide with postoperative outcomes of older patients undergoing transcatheter aortic valve replacement.
Huang YC; Chang HH; Chen PL; Chu CM; Tsai JC; Wang KY
J Chin Med Assoc; 2023 May; 86(5):479-484. PubMed ID: 36930846
[TBL] [Abstract][Full Text] [Related]
2. The interaction of forced expiratory volume in 1 s and N-terminal pro-B-type natriuretic peptide with outcomes after transcatheter aortic valve replacement.
Crestanello JA; Greason KL; Mathew J; Eleid MF; Nkomo VT; Rihal CS; Bagameri G; Holmes DR; Pislaru SV; Sandhu GS; Lee AT; King KS; Alkhouli M
Eur J Cardiothorac Surg; 2023 Apr; 63(4):. PubMed ID: 36645236
[TBL] [Abstract][Full Text] [Related]
3. Different impact of aortic regurgitation assessed by aortic root angiography after transcatheter aortic valve implantation according to baseline left ventricular ejection fraction and N-terminal pro-B-type natriuretic peptide.
Kaneko H; Hoelschermann F; Schau T; Tambor G; Neuss M; Butter C
Cardiovasc Interv Ther; 2018 Jul; 33(3):232-238. PubMed ID: 28567700
[TBL] [Abstract][Full Text] [Related]
4. Impact of diastolic dysfunction on long-term mortality and quality of life after transcatheter aortic valve replacement.
Anantha-Narayanan M; Malik U; Mbai M; Megaly M; Florea V; Sharma A; Cavalcante JL; Garcia S
Catheter Cardiovasc Interv; 2020 Apr; 95(5):1034-1041. PubMed ID: 31419009
[TBL] [Abstract][Full Text] [Related]
5. Acute Heart Failure at the Time of Transcatheter Aortic Valve Replacement Does Not Increase Mortality.
Burke WT; Trivedi JR; Flaherty MP; Grubb KJ
Innovations (Phila); 2018; 13(1):47-50. PubMed ID: 29462050
[TBL] [Abstract][Full Text] [Related]
6. Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement.
Pfister R; Wahlers T; Baer FM; Scherner M; Strauch J; Erdmann E
Clin Res Cardiol; 2010 May; 99(5):301-7. PubMed ID: 20140438
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide is associated with remodeling and exercise capacity after transcatheter aortic valve replacement for aortic stenosis.
Sato K; Kumar A; Krishnaswamy A; Mick S; Desai MY; Griffin BP; Kapadia SR; Popović ZB
Clin Cardiol; 2019 Feb; 42(2):270-276. PubMed ID: 30565264
[TBL] [Abstract][Full Text] [Related]
8. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
[TBL] [Abstract][Full Text] [Related]
9. N-terminal pro-B-type natriuretic peptide is associated with clinical outcomes after transcatheter aortic valve replacement.
Yu J; Wang W
J Cardiothorac Surg; 2023 Oct; 18(1):286. PubMed ID: 37817246
[TBL] [Abstract][Full Text] [Related]
10. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry.
Mizutani K; Hara M; Iwata S; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710182
[TBL] [Abstract][Full Text] [Related]
11. Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation.
Koskinas KC; O'Sullivan CJ; Heg D; Praz F; Stortecky S; Pilgrim T; Buellesfeld L; Jüni P; Windecker S; Wenaweser P
Am J Cardiol; 2015 Nov; 116(10):1560-5. PubMed ID: 26428025
[TBL] [Abstract][Full Text] [Related]
12. Relationship between prosthesis-patient mismatch and pro-brain natriuretic peptides after aortic valve replacement.
Melina G; Angeloni E; Benedetto U; Refice S; Miceli A; Miele C; Ciavarella GM; Sinatra R
J Heart Valve Dis; 2010 Mar; 19(2):171-6. PubMed ID: 20369499
[TBL] [Abstract][Full Text] [Related]
13. Early changes in N-terminal pro-B-type natriuretic peptide levels after transcatheter aortic valve replacement and its impact on long-term mortality.
Liebetrau C; Gaede L; Kim WK; Arsalan M; Blumenstein JM; Fischer-Rasokat U; Wolter JS; Kriechbaum S; Huber MT; van Linden A; Berkowitsch A; Dörr O; Nef H; Hamm CW; Walther T; Möllmann H
Int J Cardiol; 2018 Aug; 265():40-46. PubMed ID: 29885699
[TBL] [Abstract][Full Text] [Related]
14. Impact of N-terminal pro-B-type natriuretic peptide response on long-term prognosis after transcatheter aortic valve implantation for severe aortic stenosis and heart failure.
Kaneko H; Hoelschermann F; Tambor G; Okamoto M; Neuss M; Butter C
Heart Vessels; 2019 May; 34(5):777-783. PubMed ID: 30443765
[TBL] [Abstract][Full Text] [Related]
15. Pre- and Post-Transcatheter Aortic Valve Replacement Serum Brain Natriuretic Peptide Levels and All-Cause Mortality.
Elbaz-Greener G; Ghanim D; Kusniec F; Rabin A; Sudarsky D; Carasso S; Czeiger T; Shoan-Dayan M; Sakhnini A; Grosman-Rimon L; Strauss BH; Wijeysundra HC; Amir O
Cardiology; 2020; 145(12):813-821. PubMed ID: 33070124
[TBL] [Abstract][Full Text] [Related]
16. Elevated N-terminal pro C-type natriuretic peptide is associated with mortality in patients undergoing transcatheter aortic valve replacement.
Hu P; Chen H; Wang LH; Jiang JB; Li JM; Tang MY; Guo YC; Zhu QF; Pu ZX; Lin XP; Ng S; Liu XB; Wang JA
BMC Cardiovasc Disord; 2022 Apr; 22(1):164. PubMed ID: 35413789
[TBL] [Abstract][Full Text] [Related]
17. [Impact of bicuspid aortic valve or tricuspid aortic valve on hemodynamics and left ventricular reverse remodeling in patients after transcatheter aortic valve replacement].
Zhang JQ; Chi CW; Zhao WL; Meng QT; Wang LD; Liu JY; Sun FZ; Zhang SL; Liu JH
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Dec; 50(12):1193-1200. PubMed ID: 36517440
[No Abstract] [Full Text] [Related]
18. Effectiveness and safety of transcatheter aortic valve replacement in elderly people with severe aortic stenosis with different types of heart failure.
Dong M; Wang L; Tse G; Dai T; Wang L; Xiao Z; Liu T; Ren F
BMC Cardiovasc Disord; 2023 Jan; 23(1):34. PubMed ID: 36653770
[TBL] [Abstract][Full Text] [Related]
19. Post-procedural N-terminal pro-brain natriuretic peptide predicts one-year mortality after transcatheter aortic valve implantation.
Vale NC; Campante Teles R; Madeira S; Brito J; Sousa Almeida M; Nolasco T; Abecasis J; Rodrigues G; Carmo J; Furstenau M; Ribeiras R; Neves JP; Mendes M
Rev Port Cardiol (Engl Ed); 2018 Jan; 37(1):67-73. PubMed ID: 29317115
[TBL] [Abstract][Full Text] [Related]
20. Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry.
Chen S; Redfors B; O'Neill BP; Clavel MA; Pibarot P; Elmariah S; Nazif T; Crowley A; Ben-Yehuda O; Finn MT; Alu MC; Vahl TP; Kodali S; Leon MB; Lindman BR
Eur Heart J; 2020 Feb; 41(8):958-969. PubMed ID: 31883339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
